AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Serum biomarkers in the diagnosis and prognosis of traumatic spinal cord injury: A systematic review and meta-analysis

Zhengwang Liua, Haifeng Gaob, Yidi Mana, Xiaoyu Zhanga, Liang Chenb, Mingliang Yangb, Yingli Jingc( ), Jun Lib( )
School of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, Shandong, China
Department of Spinal and Neural Reconstruction, Beijing Bo'ai Hospital, China Rehabilitation Research Center, Beijing 100068, China
Institute of Rehabilitation Medicine, China Rehabilitation Science Institute, Beijing 100068, China
Show Author Information

Abstract

Traumatic spinal cord injury (TSCI) is a severe neurological condition that frequently leads to permanent disability. Serum inflammatory markers and structural proteins may serve as potential biomarkers for TSCI. The present study aimed to evaluate the diagnostic and prognostic value of serum biomarkers in TSCI. In this article, a comprehensive literature search was conducted using databases such as Wanfang, VIP Database, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, PubMed, Cochrane Library, Embase, and Web of Science. Meta-analysis was performed using RevMan 5.4 software to compare serum biomarker concentrations between TSCI patients and healthy controls (diagnostic group) and between patients with favorable and unfavorable prognoses (prognostic group). The quality of the included studies was evaluated using the Newcastle–Ottawa Scale. The results showed that: (1) In the diagnostic group, the meta-analysis revealed that serum levels of NSE, MIF, S100β, TNF-α, IL-1β, IL-4, IL-6, IL-16, CCL2, CCL4, CCL21, CXCL1, CXCL9, CXCL10, and CXCL12 were significantly elevated in TSCI patients compared with healthy controls, while IL-10 levels were decreased. (2) In the prognostic group, meta-analysis indicated that serum GFAP and NSE concentrations were significantly lower in patients with favorable prognoses than in those with poor prognoses. In conclusion, the serum levels of most structural proteins and inflammatory factors in patients with TSCI are elevated compared with healthy controls, and patients with poor prognosis exhibit even higher concentrations than those with favorable outcomes. These findings indicate the potential value of these markers for diagnosing TSCI and assessing prognosis.

Electronic Supplementary Material

Download File(s)
jnrt-13-5-100227_ESM.docx (688.9 KB)

References

【1】
【1】
 
 
Journal of Neurorestoratology

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Liu Z, Gao H, Man Y, et al. Serum biomarkers in the diagnosis and prognosis of traumatic spinal cord injury: A systematic review and meta-analysis. Journal of Neurorestoratology, 2025, 13(5). https://doi.org/10.1016/j.jnrt.2025.100227

1842

Views

5

Crossref

3

Web of Science

5

Scopus

Received: 09 March 2025
Revised: 27 April 2025
Accepted: 07 May 2025
Published: 01 October 2025
© 2025 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).